Skip to Content

Office of Research and Grant Development

Program Details

Mary Kay Foundation: REQUEST FOR PROPOSALS Innovative/Translational Cancer Research(ovarian, uterine, breast or cervical cancer)

The Offices of Research and Corporate and Foundation Philanthropy are pleased to coordinate an internal call for proposals to the Mary Kay Foundation.

The Mary Kay Foundation is a non-profit public foundation, which focuses on funding research for innovative grants for translational research in ovarian, uterine, breast or cervical cancer.

Translational research is broadly defined as research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in diagnosis, prognosis, prevention, or treatment of the cancer.

Only one grant application will be accepted from each accredited invited institution.

Application Requirements & Guidelines:
- Grants are by invitation only.
- Only one grant application will be accepted from each accredited cancer research institute
or medical school. It is up to each institute to conduct an internal review process to determine
their applicant. No exceptions.
- Principal Investigator must be appointed a full-time assistant professor or higher at the time
of application submission and commit a minimum 5% effort.
- All text and general page formatting guidelines should adhere to NIH-format, which can be
referenced on the NIH website.

The grant will be up to $100,000 (combined direct and indirect costs) for a two-year period.

To respond to the internal call, please submit a 2-page research description and an NIH-formatted CV to Beth Herron in the Research and Grant Development Office at 777-2885 or by November 2, 2022.

Mary Kay Foundation deadline is February 1, 2023.

For more information: file:///C:/Users/Richard/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/OF4YW33Z/2023%20MKAF%20RFP.pdf

Office of Research and Grant Development

    Challenge the conventional. Create the exceptional. No Limits.